| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1092337803 |
| P356 | DOI | 10.1038/ONC.2017.393 |
| P932 | PMC publication ID | 6545484 |
| P698 | PubMed publication ID | 29059173 |
| P2093 | author name string | Y Qin | |
| X Fan | |||
| H Zhou | |||
| J Fu | |||
| X Yu | |||
| L Song | |||
| Z Zhuang | |||
| J Ling | |||
| S Ji | |||
| P J Chiao | |||
| P2860 | cites work | SLUG is required for SOX9 stabilization and functions to promote cancer stem cells and metastasis in human lung carcinoma | Q23920671 |
| Genetics and biology of pancreatic ductal adenocarcinoma | Q26765438 | ||
| The Mcm2-7 replicative helicase: a promising chemotherapeutic target | Q26861045 | ||
| Initiating DNA synthesis: from recruiting to activating the MCM complex | Q28209642 | ||
| Deciphering the mechanisms of tumorigenesis in human pancreatic ductal epithelial cells | Q30536268 | ||
| Beta-catenin blocks Kras-dependent reprogramming of acini into pancreatic cancer precursor lesions in mice | Q33604913 | ||
| Secreted interleukin-1alpha induces a metastatic phenotype in pancreatic cancer by sustaining a constitutive activation of nuclear factor-kappaB | Q33799457 | ||
| Oncogenic activation of NF-kappaB. | Q33849388 | ||
| Cooperativity of oncogenic K-ras and downregulated p16/INK4A in human pancreatic tumorigenesis | Q33910221 | ||
| Modulation of pancreatic cancer chemoresistance by inhibition of TAK1 | Q35143975 | ||
| MDC1 functionally identified as an androgen receptor co-activator participates in suppression of prostate cancer. | Q35656832 | ||
| Eukaryotic MCM proteins: beyond replication initiation | Q35684975 | ||
| MDC1 Enhances Estrogen Receptor-mediated Transactivation and Contributes to Breast Cancer Suppression | Q35891320 | ||
| KrasG12D-induced IKK2/β/NF-κB activation by IL-1α and p62 feedforward loops is required for development of pancreatic ductal adenocarcinoma. | Q35990138 | ||
| NF-kB in development and progression of human cancer | Q36108761 | ||
| SOX9, a potential tumor suppressor in cervical cancer, transactivates p21WAF1/CIP1 and suppresses cervical tumor growth | Q36299791 | ||
| Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism | Q36319414 | ||
| Signaling networks controlled by the MRN complex and MDC1 during early DNA damage responses | Q36476150 | ||
| Upregulation of sex-determining region Y-box 9 (SOX9) promotes cell proliferation and tumorigenicity in esophageal squamous cell carcinoma | Q36544540 | ||
| NF-kappa B as a target for cancer therapy | Q36709532 | ||
| MDC1 regulates intra-S-phase checkpoint by targeting NBS1 to DNA double-strand breaks | Q36837486 | ||
| Epigenetic regulation of SOX9 by the NF-κB signaling pathway in pancreatic cancer stem cells | Q37179115 | ||
| The cellular response to DNA damage: a focus on MDC1 and its interacting proteins | Q37843633 | ||
| Roles for KRAS in pancreatic tumor development and progression | Q38102106 | ||
| Sox9 and programming of liver and pancreatic progenitors | Q38103364 | ||
| The role of SOX9 transcription factor in pancreatic and duodenal development | Q38117400 | ||
| Transcriptional up-regulation of Sox9 by NF-κB in endometrial carcinoma cells, modulating cell proliferation through alteration in the p14(ARF)/p53/p21(WAF1) pathway | Q39331266 | ||
| Bone morphogenetic protein 4 (BMP4) is required for migration and invasion of breast cancer | Q39428841 | ||
| Notch 2-positive progenitors with the intrinsic ability to give rise to pancreatic ductal cells | Q40415546 | ||
| Inhibition of constitutive NF-kappa B activity by I kappa B alpha M suppresses tumorigenesis | Q40666413 | ||
| Growth and metastasis of lung adenocarcinoma is potentiated by BMP4-mediated immunosuppression | Q41689907 | ||
| Identification of Sox9-dependent acinar-to-ductal reprogramming as the principal mechanism for initiation of pancreatic ductal adenocarcinoma | Q41856856 | ||
| Prognostic value of interleukin 2 and interleukin 15 in peritumoral hepatic tissues for patients with hepatitis B-related hepatocellular carcinoma after curative resection | Q44476147 | ||
| Clinical implication of Sox9 and activated Akt expression in pancreatic ductal adenocarcinoma | Q44907312 | ||
| GSEA-P: a desktop application for Gene Set Enrichment Analysis. | Q51909999 | ||
| Novel SOX9 expression during human pancreas development correlates to abnormalities in Campomelic dysplasia. | Q52117028 | ||
| SOX9 expression predicts relapse of stage II colon cancer patients. | Q53147256 | ||
| SOX9 regulates ERBB signalling in pancreatic cancer development. | Q53229089 | ||
| The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells | Q77904111 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 912-923 | |
| P577 | publication date | 2017-10-23 | |
| P1433 | published in | Oncogene | Q1568657 |
| P1476 | title | SOX9 activity is induced by oncogenic Kras to affect MDC1 and MCMs expression in pancreatic cancer | |
| P478 | volume | 37 |
| Q64259744 | Exopolysaccharide, Isolated From a Novel Strain lw01 Possess an Anticancer Effect on Head and Neck Cancer - Genetic and Biochemical Evidences |
| Q58697838 | Fibroblast Growth Factor 10 in Pancreas Development and Pancreatic Cancer |
| Q92773787 | Immune-related somatic mutation genes are enriched in PDACs with diabetes |
| Q92383002 | In silico identification of EP400 and TIA1 as critical transcription factors involved in human hepatocellular carcinoma relapse |
| Q90375389 | LOTUS: A single- and multitask machine learning algorithm for the prediction of cancer driver genes |
| Q98906859 | MYEOV increases HES1 expression and promotes pancreatic cancer progression by enhancing SOX9 transactivity |
| Q89848838 | Mitochondrial Protein UQCRC1 is Oncogenic and a Potential Therapeutic Target for Pancreatic Cancer |
| Q99634411 | Roles for MDC1 in cancer development and treatment |
| Q60909293 | SOX9 is a dose-dependent metastatic fate determinant in melanoma |
| Q91838151 | The impact of TP53BP1 and MLH1 on metastatic capability in cases of locally advanced prostate cancer and their usefulness in clinical practice |
| Q64063248 | miR-1-3p suppresses proliferation of hepatocellular carcinoma through targeting SOX9 |
Search more.